Navigation Links
Biotech Finishes on a High in August, Burrill Report Says
Date:9/4/2007

on shares at $11.50 each, 23% below the midpoint of the proposed $14-$16 price range. Its shares jumped 10.8% by the end of August.

Eight companies added themselves to the IPO runway:

-- Adnexus Therapeutics, which is focused on discovering, developing, and

commercializing the proprietary drug class called Adnectins. Adnexus'

first product candidate, Angiocept (CT-322), is in Phase 1 clinical

development in oncology in the United States. Adnectins are designed

and optimized using PROfusion, the company's patented protein design

engine that enables rapid optimization of protein therapeutics.

-- Anacor Pharmaceuticals, which is developing novel small-molecule

therapeutics derived from boron chemistry. The company has focused

initially on developing topical applications of its compounds to treat

fungal, bacterial and inflammatory diseases and its most advanced

product candidate is AN2690, a topical antifungal in development for

the treatment of toenail onychomycosis, which is a fungal infection of

the nail and nail bed.

-- ARYx Therapeutics, focuses on discovering and developing product

candidates designed to eliminate known safety issues associated with

commercially successful drugs,

-- Biolex Therapeutics is developing recombinant human therapeutic

proteins and monoclonal antibodies that, until now, have been

impossible or very expensive to develop in existing protein expression

systems.

-- Genoptix, Inc., a certified laboratory headquartered in Carlsbad,

California, provides personalized medicine services to hematologists

and oncologists that combine proprietary and exclusive tests with

advanced clinical techniques for comprehensive evaluation of individual

patients.

-- Insys Therapeutics, which focuses on discovering, developing and

'/>"/>
SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... (PRWEB) February 28, 2015 In recent years ... number of practicing physicians as a way for them to ... education regarding Cannabis as medicine. Since the FDA still lists ... few resources available to licensed physicians that can help ... patient. Dr. Deborah Malka in Santa Cruz, CA is ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 With their ... Fitness has added an additional exercise to their already ... oblique exercise is most commonly known as, is often ... “Rope Pulls” are executed in a relatively safe manner ... and strength levels. The full description of “Rope Pulls” ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Mew and ... announced that they now provide business consulting services in ... as corporate tax planning and succession planning. Company finances ... to experienced professionals. On top of this, complex Canadian ... handle corporate accounting. As a result, Mew and Company ...
(Date:2/28/2015)... 28, 2015 For those people who ... the Mesothelioma Applied Research Foundation (Meso Foundation) ... March 3, starting at 9:30 AM. , The live ... The broadcast can be accessed through any browser on ... , The Symposium is a unique event that covers ...
(Date:2/28/2015)... Pismo Beach, CA (PRWEB) February 28, 2015 ... the needs of Central Coast area residents, recently announced ... Whitening System. It’s a treatment option for new ... patients kick off 2015 with a bright, white smile, ... the discounted price of $299, marked down from the ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2
... Cardiva Medical, Inc. announced today that it has received ... for its latest technology, the Cardiva Catalyst III, which ... in the market. Built upon its predecessor, the ... which neutralizes heparin in the tissue adjacent to the ...
... 19 Nuvilex, Inc. (OTC Bulletin Board: NVLX), an ... aesthetics, dermatology, environmental and nutraceutical products, today announced that ... Tuesday, June 2, 2009 at 4:30 PM Eastern Time. ... (U.S.) and 1-201-689-8471 (international). The call will also ...
... (www.meettheburns.com) targets first time athlete,s foot sufferers and ... Schering-Plough Corporation (NYSE: SGP ) ... antifungal spray for the treatment of athlete,s foot. ... spray and deodorant powder spray.(Photo: http://www.newscom.com/cgi-bin/prnh/20090519/NY19030 ...
... profile "New Strategies for Optimizing CHO Performance" inside the BIO Process ... ... Fort Collins, CO (PRWEB) May 19, 2009 -- Amidst ... International Convention will be InVitria, a cell culture media supplement company ...
... patient with help from GI specialists, GI Monitor, an ... (IBD) Crohn,s and Ulcerative Colitis to track their symptoms ... N.J., May 19 WellApps, Inc. launched an iPhone ... Colitis provide accurate symptom data to their doctors for ...
... May 19 Regulatory processes differ across continents, ... pressing need to integrate the regulatory environment of ... regulations impact drug launches as less price controlled ... in regulated markets. The pharmaceutical industry, along with ...
Cached Medicine News:Health News:Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device 2Health News:Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device 3Health News:Nuvilex, Inc. Announces Monthly Investor Conference Call 2Health News:Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males 2Health News:InVitria to Present at BIO 2009 International Convention in Atlanta 2Health News:IBD Patient Launches iPhone Application to Help Doctors Treat Crohn's and Ulcerative Colitis 2Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 2Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 3Health News:Transatlantic Regulatory Integration of Drug Approval Process Vital for the Global Pharmaceutical Industry, Notes Frost & Sullivan 4
(Date:2/27/2015)... and JERUSALEM , Feb. 27, 2015 ... octreotide capsules, its lead product for the orphan condition ... Series E financing round. Participants in the financing included ... an undisclosed blue chip public investment fund, as well ... Health Ventures, Abingworth and ARCH Venture Partners. ...
(Date:2/26/2015)... 26, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today announced ... shares of its common stock at a price to ... to Tandem from this offering are expected to be ... other estimated offering expenses payable by Tandem. All of ...
(Date:2/26/2015)... BEND, Ind. , Feb. 26, 2015  Mobility ... announce an agreement with Bank of America (NYSE: ... consumers nationwide to receive financing of the revolutionary MV-1 ... vehicle, designed from the ground up to provide safe ... Approved applicants can use their loan to purchase a ...
Breaking Medicine Technology:Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Reportlinker.com announces that a new market research report ... Sanofi-Aventis: PharmaVitae Profile http://www.reportlinker.com/p0201760/Sanofi-Aventis-PharmaVitae-Profile.html ... examines the historical and forecast performance for Sanofi-Aventis ... company strategy, portfolio and pipeline analysis and assessment ...
... As technologies for fat removal become more advanced, physicians ... the body but also recycling the fat to further ... recent statistics from the American Society for Aesthetic Plastic ... two most popular invasive and non-invasive cosmetic procedures in ...
Cached Medicine Technology:Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 2Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 3Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 4Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 5Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 6Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile 7The New Face of Body Contouring 2
... PC captures, displays, replays and analyzes ... proven to be effective in evaluating ... obstructive pulmonary disease.,It provides objective evidence ... , , Waveform and time-expanded ...
... Acoustic Cardioscan Viewer Phonocardiogram (PCG). The ... allows you to record, condition, display and ... stethoscope. The product acquires and displays ... to four sites, and allows user-selectable filtering ...
... The MULTIVIEW WORKSTATION enhances patient ... access, rapid assessment, decision support, and ... hospital. Part of the INFINITY Patient ... comprehensive patient information, including continuous, real-time ...
... The biograph 16 offers the ... disease diagnosis and treatment in ... delivers high-quality PET/CT whole body ... minutes. Our comprehensive suite of ...
Medicine Products: